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We propose a model of antibiotic diffusion through a bacterial biofilm when diffusion and/or
absorption barriers develop in the biofilm. The idea of this model is: We deduce details of the
diffusion process in a medium in which direct experimental study is difficult, based on probing dif-
fusion in external regions. Since a biofilm has a gel-like consistency, we suppose that subdiffusion
of particles in the biofilm may occur. To describe this process we use a fractional subdiffusion-
absorption equation with an adjustable anomalous diffusion exponent. The boundary conditions at
the boundaries of the biofilm are derived by means of a particle random walk model on a discrete
lattice leading to an expression involving a fractional time derivative. We show that the temporal
evolution of the total amount of substance that has diffused through the biofilm explicitly depends
on whether there is antibiotic absorption in the biofilm. This fact is used to experimentally check
for antibiotic absorption in the biofilm and if the biofilm parameters change over time. We pro-
pose a four-stage model of antibiotic diffusion in biofilm based on the mentioned above physical
characteristics. The biological interpretation of the stages, in particular their relation with the bac-
terial defence mechanisms, is discussed. Theoretical results are compared with empirical results of
ciprofloxacin diffusion through Pseudomonas aeruginosa biofilm, and ciprofloxacin and gentamicin
diffusion through Proteus mirabilis biofilm.
PACS numbers:
I. INTRODUCTION
We present a model of antibiotic diffusion through
a bacterial biofilm in which absorption of antibiotic
molecules can occur. Since a biofilm has a gel-like con-
sistency, we suppose that subdiffusion of particles in the
biofilm may occur. To describe this process we use a
fractional subdiffusion-absorption equation. The model
is of a general nature and can be used to study diffu-
sion processes in media in which experimental diffusion
investigations are difficult. The application of this model
is based on the idea: We can specify details of the diffu-
sion process in a medium in which experimental diffusion
study is difficult, based on diffusion properties observed
in external regions. Experimental methods based on the
model are non–invasive to the biofilm. We show that
the temporal evolution of the total amount of substance
that has diffused through the medium explicitly depends
on whether there is absorption of diffusing particles in
the medium. We divide the process into different stages
according to the following criteria: (a) whether there is
absorption of diffusing particles in the medium or not,
(b) whether the diffusion and absorption parameters are
constant or change over time. The potential application
of this model goes beyond the specific problem we use as a
guiding example. Namely it is a generic model to deduce
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diffusion properties from the particle currents exchanged
with the direct environment.
The model is used to experimentally check for antibi-
otic absorption in the biofilm and whether the biofilm
parameters change over time. We define four stages in
antibiotic diffusion-absorption process in a biofilm ac-
cording to the criteria how points (a) and (b) are met.
The division into stages is made according to physical,
not biological criteria. However, determining the order
of stages and its duration may help in the biological in-
terpretation of antibiotic interaction with bacteria pro-
cesses. We present possible criteria which of the biofilm
defence mechanisms can be considered as dominant at
each stage. However, this topic is still open and requires
further research, as more such mechanisms are being dis-
covered.
Bacterial biofilms play a key role in persistent infec-
tions. Bacteria in a biofilm develop increased resistance
of antimicrobial agents. There are many ways to defend
the bacteria against antibiotic molecules. Transport lim-
itation is an important factor in the antimicrobial resis-
tance of biofilm bacteria [1–5]. One of the symptoms of
bacterial defence against antibiotics is to slow down the
diffusion and retain antibiotic molecules in the biofilm.
Observation of antibiotic diffusion through a bacterial
biofilm allows one to understand the physical and bio-
logical processes occurring in the biofilm.
Models of antibiotic diffusion in the biofilm take into
account specific changes in the biofilm resulting from the
defence of bacteria against the antibiotic. To describe
this process the normal diffusion or normal diffusion–
2reaction equations have been usually used [5–19]. Be-
cause the biofilm has a gel-like consistency, the move-
ment of antibiotic molecules is rather strongly hindered.
Therefore, as in gel–like media [20–27], subdiffusion may
occur in the biofilm. In this case, the subdiffusion–
reaction equation with fractional time derivative is a con-
venient approach.
One of the key problems is to find the boundary con-
ditions at the biofilm boundary. Particle random walk
models on a discrete lattice are effective at deriving
boundary conditions at the border between media. Some
models assume that there is a point at the boundary be-
tween media at which the molecule must be stopped tem-
porarily [28–32]. In another model, it is assumed that the
molecule can jump across the border between the media
without having to stop at the border [33, 34]. In gen-
eral, both models lead to different boundary conditions.
In our considerations, we assume that a molecule that
tries to get out of the biofilm can do it without having to
stop at the edge of the biofilm. Therefore, in the follow-
ing the latter model will be used to derive the boundary
conditions.
A biofilm changes as a result of bacterial interaction
with antibiotics. Bacterial defence mechanisms against
antibiotics result in specific processes, such as absorp-
tion or slowing down of diffusion of antibiotic molecules
in the biofilm, these processes may occur with varying in-
tensity. We distinguish four stages of antibiotic diffusion
in a biofilm. These stages are defined by the following
criteria: (a) if there is absorption of antibiotic molecules
in the biofilm or if absorption is absent, (b) if biofilm pa-
rameters are constant or if at least one parameter changes
over time.
Various experimental techniques are used to study the
processes occurring in the biofilm in the presence of
antibiotics, such as imaging microprocesses in biofilm,
disk diffusion methods, chromatography methods etc.
[35, 36]. Another technique for measuring the effect of
antibiotics on bacteria based on measuring the tempo-
ral evolution of the amount of a specifics antibiotic that
has diffused through the biofilm WB has been shown
in [37, 38]. We will show that the function WB dif-
fers qualitatively for the stages mentioned earlier, which
gives the opportunity to experimentally check in which
stage the process is. As examples, we show that the
theoretical function describes well empirical results of
ciprofloxacin diffusion through Pseudomonas aeruginosa
PAO1 biofilm, and ciprofloxacin and gentamicin diffusion
through Proteus mirabilis O18 biofilm [37, 38].
II. ANTIBIOTIC DIFFUSION IN A BIOFILM
Bacteria exist mainly as planktonic bacteria and in
biofilms. Biofilms are complex microbial communities of
cells embedded into a matrix of self-produced extracel-
lular polymeric substance. The organization of bacteria
in biofilm helps in defending bacteria against antibiotics.
Bacteria in biofilms have even 1000 times greater resis-
tance to antibiotics compared to bacterial plankton. In
a biofilm, bacteria have many different ways of defending
against an antibiotic. The most often considered biofilm
defence mechanisms are [1–3]: (i) the biofilm matrix may
act as a diffusion barrier, (ii) microenvironments are cre-
ated in which slower bacterial growth occurs. In these
regions, the effect of the antibiotic is weakened, because
the antibiotic act strongly mainly on fast-growing bac-
teria. Examples of this are regions where oxygen and
nutrient access are reduced, (iii) the presence of persis-
ters in biofilm. The persisters are small subpopulation
of bacteria which weaken the effect of antibiotic, (iv)
the resistance genes which regulate the biofilm defence
mechanism. Which way of defence is dominant depends
on both a biofilm and the specific antibiotic. In addi-
tion to the above, there are many other factors, such as
some nontoxic colloidal particles [39] and increased extra-
cellular polymeric substance production in older biofilms
[40], that increase the defence ability of bacteria against
the action of antimicrobial molecules. Bacteria may also
exchange DNA pieces and pass on successful mutations
increasing the immune properties of the biofilm. Quo-
rum sensing is a cell-to-cell communication phenomenon
which affects the cell population density and regulates
their behaviour. This phenomenon also influences the
increase of biofilm resistance to the antibiotic [1, 2, 41].
As we mentioned earlier, models of antibiotic diffusion
in a biofilm have been based mainly on normal diffu-
sion or normal diffusion-reaction equations. In [6] the
interaction of an antibiotic with the biofilm was mod-
elled taking into account the antibiotic depletion process
and reduced bacterial growth rates in biofilm. Normal
diffusion-reaction equation with different reaction terms
were considered in [7]. In both papers simple bound-
ary conditions at the biofilm boundaries are assumed,
namely, vanishing of the diffusion flux of the antibiotic or
keeping a constant antibiotic concentration at the biofilm
boundaries. The diffusion–adsorption equation has been
used to describe antibiotic diffusion in a Pseudomonas
aeruginosa bioflim [12]. This equation is equivalent to
the normal diffusion equation with diffusion coefficient
controlled by an adsorption parameter. Normal diffu-
sion equations taking into account the absorption and
desorption processes were used to model transport of
ciprofloxacin and levofloxacin in Pseudomonas aerugi-
nosa biofilms [8]. In addition to the diffusion of an-
tibiotics, other factors affecting the biofilm have been
included in the models, such as oxygen diffusion into
biofilm [15], influence of persister cells to antibiotic diffu-
sion [42], and the quorum sensing phenomenon [13, 41].
Here we present an alternative approach based on a
fractional diffusion mechanism. We explicitly derive the
corresponding boundary value problem involving a frac-
tional time derivative. Our results are shown to be con-
sistent with experimental observations in two different
biofilm–forming species.
3III. MODEL
In this section, we present the system, the general
assumptions adopted in the model, and the boundary
conditions at the border between biofilm and normal–
diffusion medium.
A. System
Our considerations concern a three–dimensional sys-
tem which is homogeneous in the plane perpendicular to
the x axis. Thus, later in this paper we treat this sys-
tem as one–dimensional. We consider the system which
is schematically presented in Fig. 1. The system consists
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FIG. 1: Schematic of the system. The biofilm separates two
regions in which normal diffusion occurs, D is the normal dif-
fusion coefficients in regions A and B, DM is the subdiffusion
coefficient, α is the subdiffusion parameter and κ is the ab-
sorption coefficient in the biofilm, qA and qB are probabilities
of stopping a diffusing particle by the biofilm boundaries.
of three parts: A, (−∞, x1), and B, (x2,∞), represent
normal diffusion media, the middle partM , (x1, x2), rep-
resents a biofilm. A molecule that attempts to jump from
the media A or B to the biofilm can do it with probabili-
ties 1−qA and 1−qB , respectively. A molecule that tries
to get out of the biofilm can do it without any hindrance.
B. Assumptions
The model of diffusion of antibiotic molecules through
a biofilm is based on the following assumptions:
(i) There may be subdiffusion in the biofilm. Subdif-
fusion is due to the complex structure of the medium,
which makes diffusion of molecules very difficult [43, 44].
Indeed, the polymeric structure connecting cells in a
biofilm is similar to gels, e.g. aqueous agarose solution
[20, 21, 33]. Moreover, similar to mucus, charge effects
may came into play. In many cases diffusion in similar
environments may be anomalous. We therefore base our
description on subdiffusion of antibiotic molecules in a
biofilm, although normal diffusion is included as a limit-
ing case.
(ii) Absorption of antibiotic molecules may occur in
the biofilm. Absorption is treated here as an irreversible
reaction, the result of which is to switch off the antibi-
otic molecule from further action. The molecule can be
invoked in a dense biofilm or it can interact with the
bacterium.
(iii) We use an approximation of a homogeneous
biofilm. We assume that the subdiffusion and absorp-
tion parameters in the biofilm do not depend on the spa-
tial variable. This assumption has been often used in
the models presented in the articles cited in the previous
sections.
(iv) The antibiotic molecule that attempts to jump from
a diffusion medium to a biofilm can do it with a certain
probability, and the molecule that tries to leave a biofilm
will do it without any hindrances. The problem of getting
an antibiotic molecule inside the biofilm can be caused
by biofilm defence mechanisms. Moreover, a molecule
that tries to jump into a biofilm from an external diffu-
sive medium has to hit one of the channels in the biofilm.
A molecule that tries to get out of the biofilm does not
encounter such obstacles. Although we use the approx-
imation of a homogeneous biofilm, we assume that the
probabilities of retaining diffusing molecules at biofilm
surfaces qA and qB may be different. The motivation for
this assumption is that the external concentrations of the
antibiotic, which may be different at both biofilm bound-
aries, affect bacterial defence mechanisms at the bound-
aries. We also assume that the boundaries of the biofilm
do not significantly change their position over time.
(v) Parameters of subdiffusion and/or absorption in
the biofilm can change over time; in the considerations
we use a ‘quasistatic approximation’. It is supposed
that the subdiffusion–absorption process in the biofilm
is slow. Then, the solutions to the equation with param-
eters changing over time will be obtained in the following
way. First, we will solve the equation with fixed param-
eters and then we will change the parameters into time-
dependent functions. This assumption is consistent with
the concept of the stationary phase in the modelling of
antibiotic diffusion in the biofilm [1, 45].
C. Equations
We assume that in parts A, M , and B of the system
the process is described by the following equations
∂CA(x, t)
∂t
= D
∂2CA(x, t)
∂x2
, (1)
∂CM (x, t)
∂t
= DM
∂1−α
∂t1−α
[
∂2CM (x, t)
∂x2
− κ2CM (x, t)
]
, (2)
∂CB(x, t)
∂t
= D
∂2CB(x, t)
∂x2
, (3)
where DM has physical dimension m
2/secα. The
Riemann–Liouville fractional derivative, which is present
in Eq. (2), is defined for 0 < β < 1 as
dβf(t)
dtβ
=
1
Γ(1− β)
d
dt
∫ t
0
dt′
f(t′)
(t− t′)β . (4)
4The diffusive fluxes are defined as
JA,B(x, t) = −D∂CA,B(x, t)/∂x and JM (x, t) =
−DM (∂1−α/∂t1−α)∂CM (x, t)/∂x.
For α = 1 we have normal diffusion whereas for
0 < α < 1 there is subdiffusion. The appearance of
the fractional time derivative in the subdiffusion equa-
tion means that the process is non-Markovian with a long
memory. In this case, according to the Continuous Time
Random Walk model, the time distribution for the next
jump of the molecule ψ has a heavy tail, ψ(t) ∼ 1/t1+α
when t→∞, which gives rise to an infinite characteristic
sojourn time 〈t〉 [43].
D. Boundary conditions
It is essential to determine the boundary conditions at
the boundaries of the biofilm. In order to derive them
we use the particle random walk model in a system with
a one–sided fully permeable wall [34]. Within the model
we assume that both variables, the particle position m
and time n, are discrete. Finally, we move to continuous
variables x and t. As an example, we derive the bound-
ary conditions at x1. Since the boundary conditions for
normal diffusion and subdiffusion are local, for the sake
of simplicity we assume that there is one partially per-
meable wall in the system located between sites N and
N +1, which corresponds to the biofilm boundary at x1,
see Fig. 2. The difference equations describing a random
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FIG. 2: Random walk of a particle in a discrete system with
one–sided fully permeable wall represented by the vertical
line, more detailed description in the text.
walk in this system are
PA,n+1(m;m0) =
1
2
PA,n(m− 1;m0) (5)
+
1
2
PA,n(m+ 1;m0), m ≤ N − 1,
PA,n+1(N ;m0) =
1
2
PA,n(N − 1;m0) (6)
+
1
2
PM,n(N + 1;m0) +
qA
2
PA,n(N ;m0),
PM,n+1(N + 1;m0) =
1− qA
2
PA,n(N ;m0) (7)
+
1
2
PM,n(N + 2;m0)−RPM,n(N + 1;m0),
PM,n+1(m;m0) =
1
2
PM,n(m− 1;m0) (8)
+
1
2
PM,n(m+ 1;m0)−RPM,n(m;m0), m ≥ N + 2,
where Pi,n(m;m0) is the probability to find the parti-
cle at site m in region i after n steps, m0 is the initial
position of the particle, and R is the probability of parti-
cle absorption in the medium M . The Green’s functions
for continuous time, in terms of the Laplace transform
Pˆ (m, s) ≡ L[P (m, t)] ≡ ∫∞0 exp(−st)P (m, t)dt, is
Pˆi(m, s;m0) =
1− ψˆi(s)
s
Si(m, ψˆi(s);m0), (9)
where Si(m, z;m0) =
∑∞
n=0 z
nPi,n(m;m0) is the gener-
ating function, and ψi is the probability density of time
which is needed for the particle to take its next step
in the medium i. Moving from discrete to continuous
spatial variable we use the following relations x = ǫm,
x1 = ǫN , x0 = ǫm0, and Pˆ (x, s;x0) = Pˆ (m, s;m0)/ǫ,
where ǫ is the distance between neighbouring sites. We
then take the limit of small ǫ. As it was shown in [34],
the following functions ψˆA(s) = 1/(1 + ǫ
2s/2D) and
ψˆM (s) = 1/(1 + ǫ
2sα/2DM ) should be taken into con-
sideration. The relation between probability R and the
absorption coefficient κ defined in the system with con-
tinuous variables is R = κ2ǫ2/2.
Let us assume that the molecule is in region A initially,
such that the initial conditions are PA,0(m;m0) = δm,m0
and PM,0(m;m0) = 0. After some calculations we get
(details are presented in Appendix I)
PˆA(x, s;x0) =
1
2
√
Ds
[
e−|x−x0|
√
s
D (10)
+
√
s
D − (1− qA)
√
κ2 + s
α
DM√
s
D + (1− qA)
√
κ2 + s
α
DM
e−(2x1−x−x0)
√
s
D
]
,
PˆM (x, s;x0) =
(1− qA)sα−1
DM
(√
s
D + (1− qA)
√
κ2 + s
α
DM
) (11)
× e−(x1−x0)
√
s
D−(x−x1)
√
κ2+ s
α
DM .
The Laplace transforms of diffusive fluxes read
JˆA(x, s;x0) = −D∂PˆA(x, s;x0)
∂x
, (12)
JˆM (x, s;x0) = −DMs1−α ∂PˆM (x, s;x0)
∂x
. (13)
Combining the values of the functions Eqs. (10)–(13)
calculated at x1 we get the boundary conditions in terms
of the Laplace transform
(1 − qA)DPˆA(x−1 , s;x0) = DMs1−αPˆM (x+1 , s;x0), (14)
5JˆA(x
−
1 , s;x0) = JˆM (x
+
1 , s;x0). (15)
Using the formula L−1[sβ fˆ(s)] = ∂βf(t)/∂tβ, 0 < β < 1,
we obtain the boundary conditions in the time domain
(1− qA)DPA(x−1 , t;x0) = DM
∂1−αPM (x+1 , t;x0)
∂t1−α
, (16)
JA(x
−
1 , t;x0) = JM (x
+
1 , t;x0). (17)
Assuming that the molecules diffuse independently of
one another and all diffusing particles are initially located
in the medium A, the concentration of molecules can be
calculated by means of the formula
CA,M (x, t) =
∫ x1
−∞
PA,M (x, t;x0)CA(x0, 0)dx0. (18)
Due to Eq. (18) the boundary condition for the function
P and concentration C are the same. In a similar way,
we can derive the boundary conditions at the point x2.
Then, the boundary conditions at both biofilm bound-
aries are
(1− qA)DCA(x−1 , t) = DM
∂1−αCM (x+1 , t)
∂t1−α
, (19)
JA(x
−
1 , t) = JM (x
+
1 , t), (20)
DM
∂1−αCM (x−2 , t)
∂t1−α
= (1− qB)DCB(x+2 , t), (21)
JM (x
−
2 , t) = JB(x
+
2 , t). (22)
Thus, the diffusive flux is continuous at the boundaries
between the media, and the concentration at the bound-
ary in the diffusive medium depends on the concentra-
tion in the biofilm at previous times. Such an ageing be-
haviour is not surprising in the naturally non–stationary
scenario of fractional diffusion, equivalent to a Continu-
ous Time RandomWalk with diverging 〈t〉 [46, 47]. How-
ever, when normal diffusion occurs in the biofilm, the
boundary conditions (19) and (21) assume a fixed ratio
of concentrations at each biofilm boundary.
IV. THEORETICAL RESULTS
In the following, we consider a system in which at the
initial moment there is a homogeneous solution of antibi-
otic in the part A, while in the other parts of the system
there is no antibiotic. The boundary conditions (19)–
(22) are used to solve equations (1)–(3) for the following
initial condition 

CA(x, 0) = C0 ,
CM (x, 0) = 0 ,
CB(x, 0) = 0 .
(23)
We are interested in calculating the time evolution of the
amount of antibiotic WB that has diffused through the
biofilm to region B,
WB(t) = Π
∫ ∞
x2
CB(x, t)dx, (24)
where Π is the area of a biofilm surface. The function
WB is the basis for our further consideration. Below we
present the function (24) in the long time limit. The form
of this function depends on the parameter κ. Details of
the calculations are shown in Appendix II.
A. The case of κ = 0
For κ = 0 we obtain
W0B(t) = C0Π
(
a0
√
t− b0t1−α
)
, (25)
where
a0 =
2(1− qA)
√
D
(2 − qA − qB)
√
π
, (26)
b0 = a
2
0
πd(1 − qB)
2DMΓ(2− α) , (27)
d = x2 − x1.
B. The case of κ = const. 6= 0
Assuming qA, qB 6= 1, we get for κ 6= 0
WκB(t) = C0Π
(
aκ − bκ 1√
t
− cκ 1
tα
)
, (28)
where
aκ =
1
(1− qB)κ sinh(κd) , (29)
bκ = aκ
coth(κd)√
πD
(
1
1− qA +
1
1− qB
)
, (30)
cκ = aκ
1 + κd coth(κd)
2κ2DMΓ(1− α) . (31)
The characteristic feature of the function WκB Eq. (28)
is that, unlike the function W0B , it reaches a plateau for
t≫ max((bκ/aκ)2, (cκ/aκ)1/α).
6C. Biofilm parameters change over time
The results presented in Secs. IVA and IVB have been
obtained assuming that the biofilm parameters are con-
stant. However, when the antibiotic acts on the bacteria
a biofilm structure can change and biofilm parameters
evolve over time. Since in such cases the parameters ap-
pearing in the equations and boundary conditions depend
on time, the derivation of the function WB requires addi-
tional considerations. However, we postulate the use of a
quasistatic approximation. In this approximation, we use
functions derived for constant parameters, and then as-
sume that these parameters are certain functions of time.
The simplest version of this is the following function de-
fined in the case in which antibiotic absorption occurs
and biofilm parameters change over time,
Wκ˜(t)B(t) = ρ(t)WκB(t), (32)
where ρ(t) is to be determined from experimental data.
The parameters aκ, bκ and cκ for the functionWκ˜(t)B are
the same as for WκB Eq. (28).
The usefulness of this function is shown in Sec. VI.
Assuming that κd ≪ 1, which provides sinh(κd) ≈
1/ coth(κd) ≈ κd, the function Wκ˜(t)B(t) Eq. (32) can
be obtained from the substitution
κ→ κ
ρ(t)
, 1− qA,B → (1− qA,B)ρ(t), DM → DMρ2(t)
(33)
in Eqs. (28)–(31). The above relations define the tempo-
ral evolution of the biofilm parameters if Eq. (32) holds.
V. FOUR–STAGE MODEL OF ANTIBIOTIC
DIFFUSION THROUGH A BIOFILM
Based on the results presented in Sec. IV, we divide the
process of antibiotic diffusion in a biofilm into different
stages with respect to the following physical characteris-
tics. First, the process can be with or without absorp-
tion. These differences appear to be related to the type of
bacterial defence mechanism in the biofilm. Secondly, the
process can be ‘static’, without changing any parameters,
or ‘dynamic’ when at least one of the biofilm parameters
changes over time, what is related to the development
of biofilm defence mechanisms. Considering the criteria
described above, we propose to distinguish four stages de-
scribed below in the process of antibiotics diffusion in a
biofilm. Moreover, for subdiffusion the process is ageing,
i.e. the mean mobility is a decreasing function of time.
Moreover, if we start the measurement some time after
the antibiotic first enters the biofilm, the measurement
depends on the ageing time.
It is important to link the stages with the possible
defence mechanisms of bacteria in the biofilm. Although
the relation of the defence mechanisms to the stages
is not immediately obvious, we give below examples of
biophysical interpretations of processes that may occur
in each stage. We mention here that the absorption is
treated as a permanent immobilization or disintegration
of a molecule. Formally, this process is equivalent to
diffusion with an irreversible reaction. However, if the
diffusing antibiotic molecule is immobilized temporarily
and may continue to diffuse after some time, we treat
this process as diffusion with a reversible reaction. The
parameters α, DM , qA, qB, and κ may change due to
changes in the biofilm structure. The stages are defined
as follows.
Stage I. There is no absorption of the antibiotic
in the biofilm and all biofilm parameters do not change
over time.
Examples of processes occurring at this stage are
the efflux–pump effect and the diffusion of antibiotic
molecules in a biofilm in which rapid bacterial growth
has been temporarily inhibited, e.g. by limiting the oxy-
gen or nutrient access to bacteria. In this situation the
antibiotic molecules may weakly interact with the bac-
teria because the antibiotic mainly attacks fast-growing
bacteria. The efflux pump causes rapid excretion of
antibiotic molecules from bacteria. This process can be
treated as a subdiffusion with a ‘reversible reaction’ that
is described by the equation
∂CM (x, t)
∂t
= D˜M
∂1−α
∂t1−α
∂2CM (x, t)
∂x2
, (34)
where 1/D˜M = p/Da + (1 − p)/Db, Da and Db are
coefficients describing molecule random walk outside
and inside the bacteria, respectively, p is the probability
that the current location of a molecule is outside the
bacteria. The derivation of Eq. (34) is in Appendix III.
We mention here that Eq. (34) for the normal diffusion
case was considered in [48].
Stage II. There is no absorption of the antibiotic
and at least one of the biofilm parameters change over
time.
During the initial period, when the concentration
of antibiotic in the biofilm is sub–inhibitory, the defence
of bacteria against antibiotics is not strong. Then, the
bacteria produce little extracellular polymeric substance
(EPS). The concentration of antibiotic in the biofilm
increases over time, then the EPS is getting denser,
which makes diffusion of antibiotic molecules more
difficult. However, the density of EPS does not reach
such a high concentration that irreversible retention of
the antibiotic molecules is possible.
Stage III. There is absorption of antibiotics in
the biofilm, κ 6= 0, and biofilm parameters do not change
over time.
If absorption of antibiotic molecules appears and
the values of the parameters are not changed, it may
7mean that the absorption is carried out by certain
‘absorption centers’ which have appeared as a defensive
effect of the bacteria. It is also possible that the density
of EPS has reached a constant, high value and the
retention of antibiotic molecules occurs with a constant
probability.
Stage IV. There is absorption of antibiotics in
the biofilm and at least one of the biofilm parameters
changes over time.
Examples of processes occurring at this stage are:
(a) The diffusion parameters and the absorption pa-
rameter change over time. This effect may be due to
the increasing high EPS production by bacteria. The
density of mucus is so great that it causes immobilization
of antibiotic molecules with increasing probability as
well as slowing down diffusion. (b) Only the absorption
parameter changes, the subdiffusion parameters remain
constant. Some ‘absorbing centres’ in bacteria are ac-
tivated that immobilize or destroy antibiotic molecules.
The intensity of this process increases over time as the
antibiotic concentration increases. During this time, the
production of EPS by the bacteria is not so large and
changes in subdiffusion parameters are negligibly small.
The division into stages is determined by various forms
of the function WB which can be measured experimen-
tally. Based on the empirical results discussed in [49] and
in Sec. VI, the division of the process into stages is sup-
plemented with the following remark: The order of steps
depends on both specific antibiotic and biofilm, moreover
some stages may not be observed at all. While a form of
the function in stages I and III is given by Eqs. (25) and
(28), respectively, the determination of the function for
variable parameters, stages II and IV, requires additional
considerations. We have not considered the function WB
for stage II since in the examples considered in the next
section, this stage is not observed.
VI. DIFFUSION OF CIPROFLOXACIN AND
GENTAMICIN THROUGH PSEUDOMONAS
AERUGINOSA AND PROTEUS MIRABILIS
BIOFILMS
Diffusion of the antibiotics ciprofloxacin and gen-
tamicin through Pseudomonas aeruginosa and Proteus
mirabilis biofilms was studied experimentally [37, 38].
The experimental setup described in these papers cor-
responds to the system presented in Fig. 1. At the ini-
tial moment, a homogeneous aqueous antibiotic solution
(medium A) was separated by a biofilm layer (medium
M) from pure water (medium B). For technical rea-
sons, the observation of concentration profiles was pos-
sible only in region B. Measurements were made in the
time interval 〈100 s, 2400 s〉. Concentration profiles of
diffusing substances were measured by means of laser in-
terferometry. Absorption of antibiotic can occur in the
biofilm only. Biofilms were cultured on a nucleopore
membrane. Since such a membrane is well permeable to
antibiotic molecules, we assume that this membrane did
not significantly affect the biofilm diffusion properties.
The thickness of P. mirabilis biofilm is d = 5.7×10−5 m.
In Figs. 3–5 the experimental data (symbols) and the-
oretical function WB (lines) are presented. The experi-
mental data on diffusion of ciprofloxacin through Pseu-
domonas aeruginosa PAO1 biofilm were taken from [37]
(presented in Fig. 4 in this paper) and the experimental
data on diffusion of ciprofloxacin and gentamicin through
Proteus mirabilis O18 biofilm were taken from [38] (the
data are presented in Figs. 3 and 5 in this paper).
0 500 1000 1500 2000 2500
0
1
2
3
4
5
W
B(
t) 
[1
0-
8  
m
ol
]
t [s]
FIG. 3: Experimental results (squares) and theoretical func-
tion WB0 Eq. (25) (dashed line) for diffusion of ciprofloxacin
through P. mirabilis O18 biofilm, fitting parameters are a0 =
0.90×10−5 m/√s and b0 = 0.95×10−6 m/s0.05, and α = 0.95;
here C0 = 1.5 mol/m
3 and Π = 7.0× 10−5 m2.
Analyzing the function WB obtained experimentally
for diffusion of gentamicin through P. mirabilis O18
biofilm (see Fig. 5), we note that for a long time there
persists a stage in which absorption of antibiotic occurs
and biofilm parameters change over time. In this case
we assume that the function Wκ˜(t)B is given by Eq. (32)
with ρ(t) = 1/ (a− b/t) for t > b/a, where a and b are
parameters to be determined. Thus, we get
Wκ˜(t)B(t) =
C0Π(
a− bt
) (aκ − bκ 1√
t
− cκ 1
tα
)
. (35)
The parameters aκ, bκ, and cκ are the same as for the
case of κ = const. 6= 0.
In Figs. 3–5 dashed lines represents the plot of the
function W0B Eq. (25), solid lines represents the plot of
WκB Eq. (28), and dotted–dashed lines are the plots of
Wκ˜B Eq. (35). In general, a good agreement between
the theoretical functions and the empirical results is ob-
served. In Fig. 3 the experimental data on ciprofloxacin
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FIG. 4: Experimental results (squares) and theoretical func-
tions W0B Eq. (25) (dashed line) and WκB Eq. (28) (solid
line) for diffusion of ciprofloxacin through Psudomonas aerug-
inosa biofilm, the parameters are a0 = 0.86 × 10−5 m/√s,
b0 = 1.90 × 10−5 m/s0.05, aκ = 0.44 × 10−3 m, bκ =
2.10× 10−3 m/√s, cκ = 8.57× 10−2 mol/s0.95 , and α = 0.95;
here t1 = 1560 s, C0 = 3.0 mol/m
3, and Π = 7.0× 10−5 m2.
diffusion through P. mirabilis O18 biofilm are well ap-
proximated by the function W0B for t > 1000 s. In
Fig. 4 the experimental data, presented for the case of
ciprofloxacin diffusion through the Pseudomonas aerug-
inosa PAO1 biofilm, are well described by W0B for t <
t1 = 1560 s and by WκB for t > t1. In Fig. 5 the func-
tions WκB (for t < t2 = 1000 s) and Wκ˜(t)B (for t > t2)
describe the experimental data obtained for gentamicin
diffusion through P. mirabilis O18 biofilm.
The parameter α = 0.95 ensures the best fit of theo-
retical functions Eqs. (25), (28), and (35) to the empir-
ical data. Unfortunately, the empirical data taken from
[37, 38] do not allow a reliable estimation of the mea-
surement error for this parameter. Because the biofilm
constitution is similar to the 1 % concentration of aque-
ous agarose solution for which α = 0.95 [33], the assump-
tion that there is subdiffusion in the biofilm seems to be
well-justified.
In the time interval 〈1000 s, 2400 s〉 we observed the
stage I only for ciprofloxacin diffusion through P.
mirabilis biofilm (see Fig. 3). For t < 1000 s, the ex-
perimental data are not described by Eq. (25). This
is probably due to a finite time needed for antibiotic
molecules to pass through the biofilm. In this case we
suppose that the bacterial defence mechanisms have not
been activated yet. We note that W0B Eqs. (25) and
WκB (28) have been derived in the limit of long time,
so for short time the experimental results may not be
described by the functions mentioned above. In Fig. 3
the function W0B (25) well describes the experimental
data for t > 1000 s. In the case of gentamicin diffusion
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FIG. 5: Experimental results (squares) and plots of the func-
tions WκB Eq. (28) (solid line) and Wκ˜(t)B Eq. (35) (dotted–
dashed line) for diffusion of gentamicin in the system with P.
mirabilis O18 biofilm, the parameters are aκ = 0.30 10
−3m,
bκ = 0.43 10
−3m/
√
s, cκ = 17.1 10
−3m/s0.95, α = 0.95, and
a = 1.35, b = 350 1/s, t2 = 1000 s; the experiment was
performed for C0 = 1.5 mol/m
3 and Π = 7.0 × 10−5 m2.
through P. aeruginosa biofilm stages I and III are ob-
served (Fig. 4). The interpretation is that during the
initial period t < 1560 s, when the concentration of the
antibiotic in the biofilm is sub–inhibitory, the defence of
bacteria against antibiotics is not strong and subdiffu-
sion without absorption with constant biofilm parame-
ters is observed. However, in the next period of time,
when the concentration of the antibiotic in the biofilm
increases, the antibiotic molecules can be retained or de-
stroyed in the biofilm. Then, bacteria show more active
defence against the effects of the antibiotic. Stage III
and then stage IV are observed for diffusion of gentam-
icin through P. mirabilis biofilm (Fig. 5). In this case,
the sub–inhibitory concentration of the antibiotic in the
biofilm occurs in a period of time shorter than the time of
the first measurement. Activation of the defence mecha-
nisms of bacteria causes that the antibiotic particles are
eliminated from the diffusion process initially with a con-
stant probability, and then this probability increases over
time, finally reaching a constant value when t ≫ b/a.
According to Eq. (33), the subdiffusion parameter DM
decreases and the absorption parameter κ increases over
time. In this stage thickening EPS is probably the dom-
inant bacterial defence mechanism.
The question arises whether subdiffusion or normal dif-
fusion occurs in the biofilm. For the results presented in
Figs. 3–5, the plots of W0B and WκB are best matched
with empirical results when α = 0.95. If the parameter
α is less than 1, subdiffusion occurs in the biofilm and
the process is described by subdiffusion equation with
fractional time derivative. As an example, in Fig. 6
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FIG. 6: Different stages for the situation of Fig. 4. Dashed
lines No. 1 and 2 represent W0B Eq. (25), solid lines No. 3
and 4 represent WκB Eq. (28). Lines No. 1 and 3 are for α =
0.95, lines No. 2 and 4 are for α = 1.0. The other parameters
are a0 = 0.86 × 10−5 m/√s and b0 = 1.90 × 10−5 m/s0.05
for the functions No. 1 and 2, aκ = 0.44 × 10−3 m, bκ =
2.10 × 10−3 m/√s, and cκ = 8.57 × 10−2 mol/s0.95 for the
function No. 3, and aκ = 0.42 × 10−3 m with the same bκ
and cκ as in the previous case for the function No. 4.
we present the plots of theoretical functions obtained
for α = 0.95 and α = 1.0 for diffusion of ciprofloxacin
through Psudomonas aeruginosa biofilm. We observe a
better fit of the theoretical functions to the empirical re-
sults for α = 0.95.
VII. FINAL REMARKS
We proposed and studied a four-stage model of an-
tibiotic diffusion through a biofilm, along with a possi-
ble biological interpretation of the processes occurring in
these stages. Subdiffusion of antibiotic molecules may
occur in the biofilm, in this case the transport of an an-
tibiotic in a biofilm can be described by the fractional
subdiffusion-absorption equation. Physically, this equa-
tion describes irretrievable antibiotic molecule immobil-
isation with power–law sojourn time. The above con-
clusions have been obtained by analyzing the temporal
evolution of the amount of antibiotic that has diffused
through the biofilm WB . Because the function WB is
measurable experimentally, this model gives the oppor-
tunity to experimentally check whether absorption occurs
in the biofilm and whether the biofilm parameters change
over time. The course of the process for a particular sys-
tem depends on the type of antibiotic, its concentration,
and the species of biofilm. Not all stages of the process
of antibiotic diffusion through the biofilm are always ob-
served. Moreover, in some cases the order of the stages
may be different than the one presented in Sec. VI [49].
We emphasize that the experimental measurement is not
carried out inside the biofilm, but in the outer region, and
is thus non–invasive to the biofilm. The change of biofilm
parameters is identified here with the change of param-
eters of the WB function. Such physical properties may
be useful in deriving new strategies to fight biofilms. We
mention that changes in a biofilm structure under the
influence of various external factors have been recently
intensively studied [50–53]. We believe that knowledge
of these facts can be helpful in determining which mech-
anism of bacterial defence against the effects of an antibi-
otic dominates the process under consideration. An ex-
ample of this is diffusion of ciprofloxacin through a Psu-
domonas aeruginosa biofilm. This process is presented
in Fig. 4, in which “absorption” (i.e. the elimination of
antibiotic particles from further diffusion in the biofilm)
occurs for longer time t > t1. However, it is argued in
[54] that the diffusion barrier should not appear in this
case. It can therefore be hypothesized that other biofilm
defence mechanisms have been activated that lead to the
retention or destroyed of antibiotic molecules. Another
hypothesis worth considering is that in this case the dif-
fusion barrier may depend on the concentration of the
antibiotic.
If a change in biofilm parameters is observed, it ap-
pears likely that the bacteria are actively defending them-
selves against the effects of the antibiotic. However, if
this process is followed by a stage in which the biofilm
parameters reach constant values, it probably means that
the bacteria do not increase the intensity of their defence
despite the fact that the concentration of the antibiotic in
the biofilm continues to increase. We therefore hypoth-
esize: If a process with a change in biofilm parameters
occurs and a final process is observed in which the pa-
rameters are constant when the antibiotic concentration
in the biofilm increases, the beginning of the later process
is the time at which the bacteria are not able to further
enhance an effective defence against the antibiotic using
the same defense mechanisms. A possible biological in-
terpretation is that bacteria were probably killed at that
time. For the situation presented in Fig. 5, the final pro-
cess with constant parameters occurs when the function
Wκ˜(t)B reaches a plateau.
We suppose that the temporal evolution of antibiotic
concentration has the same properties as the function
WB. In practice, this means that when calculating an-
tibiotic concentration profiles in a biofilm, one may use
the quasistatic approximation in a similar way as it has
been done for the WB function. Considering the diffu-
sion of an antibiotic in a three-dimensional space, the
boundary conditions on the biofilm boundary Eqs. (19)
and (20) can be set in a direction normal to the biofilm
surface.
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Appendix I
The generating functions of Eqs. (5)–(8) read
SA(m, z) =
η
|m−m0|
A (z) + ΛA(z)η
2N−m−m0
A (z)√
1− z2 , (36)
SM (m, z) =
ΛM (z)η
m−N−1
M (z)η
N−m0
A (z)√
(1 +Rz)2 − z2 , (37)
where ηA(z) = (1 −
√
1− z2)/z, ηM (z) = (1 +
Rz −
√
(1 +Rz)2 − z2)/z, ΛA(z) = [q − ηA(z) + (1 −
q)ηM (z)]/[1/ηA(z) − q − (1 − q)ηM (z)], and ΛM (z) =
[(1− q)(1− η2M (z))]/[1/ηA(z)− q − (1− q)ηM (z)]. Mov-
ing from discrete to continuous time, we change the vari-
able z to ψˆA(s) or ψˆM (s) in the generating functions. In
[34] there was proved that ηA depends on ψˆA(s) only,
similarly ηM depends on the ψˆM only. This rule, the
equations presented in Sec. II and the approximations
ψˆA(s) = 1 − ǫ2s/2D, ψˆM (s) = 1 − ǫ2sα/2DM provide
Eqs. (10) and (11) in the limit of small ǫ.
Appendix II
The Laplace transforms of solutions to the diffusion
equations (1)–(3) with the boundary conditions (19)–(22)
and the initial condition (23) are
CˆA(x, s) =
C0
s
− C0(1− qA)βM (s)
s
e−β(s)(x1−x) (38)
× Ξ
+
B(s) + Ξ
−
B(s)e
−2βM (s)d
Ξ+A(s)Ξ
+
B(s)− Ξ−A(s)Ξ−B(s)e−2βM (s)d
,
CˆM (x, s) =
C0(1− qA)Dβ(s)
s2−αDM
(39)
×Ξ
+
B(s)e
−βM (s)(x−x1) − Ξ−B(s)e−βM (s)(2x2−x1−x)
Ξ+A(s)Ξ
+
B(s)− Ξ−A(s)Ξ−B(s)e−2βM (s)d
,
CˆB(x, s) =
2C0(1− qA)
Ξ+A(s)Ξ
+
B(s)− Ξ−A(s)Ξ−B(s)e−2βM (s)d
(40)
×β(s)βM (s)
Ds
e−β(s)(x−x2)−βM (s)d,
where Ξ±A,B(s) = β(s)± (1− qA,B)βM (s), β(s) =
√
s/D,
βM (s) =
√
κ2 + sα/DM , and d = x2 − x1. The Laplace
transform of time evolution of amount of substance that
has diffused through the biofilm is calculated by means
of the following formula
WˆB(s) = Π
∫ ∞
x2
CˆB(x, s)dx. (41)
From Eqs. (40) and (41) we get
WˆB(s) =
2(1− qA)ΠC0β(s)βM (s) e−βM(s)d
(Ξ+A(s)Ξ
+
B(s)− Ξ−A(s)Ξ−B(s)e−2βM (s)d)sβ(s)
.(42)
We calculate the inverse Laplace transform in the limit
of small s, that corresponds to the limit of long time.
Keeping the leading terms with respect to s we obtain
WˆB(s)
ΠC0
=
{
a˜0
s3/2
− b˜0s2−α , κ = 0,
a˜κ
s − b˜κ√s − c˜κs1−α , κ 6= 0,
(43)
where a˜0 = (1 − qA)
√
D/(2 − qA − qB), b˜0 =
a˜20d(1 − qB)/DM , a˜κ = 1/[(1 − qB)κ sinh(κd)], b˜κ =
a˜κ coth(κd)[1/(1 − qA) + 1/(1 − qB)]/
√
D, c˜κ = a˜κ[1 +
κd coth(κd)]/2DMκ
2. From Eq. (43) we get Eqs. (25)
and (28).
Appendix III
In terms of the Laplace transform the general form of
the diffusion equation reads [34]
sPˆ (x, s;x0)− P (x, 0;x0) (44)
=
ǫ2sψˆ(s)
2(1− ψˆ(s))
∂2Pˆ (x, s;x0)
∂x2
.
Let the system consist of two media a and b, in which
the distributions of waiting time for a next jump are
ψˆa(s) = 1/(1+ǫ
2sα/2Da) and ψˆb(s) = 1/(1+ǫ
2sα/2Db),
respectively. The media a and b can be ”mixed up”
in the system. Currently, the molecule can be in a
medium a with probability p or in b with probability
1 − p. The distribution of waiting time for a jump is
ψˆ(s) = pψˆa(s) + (1 − p)ψˆb(s), which for small s reads
ψˆ(s) = 1− ǫ2(p/2Da + (1 − p)/2Db)sα. Then, from Eq.
(44) we get Eq. (34).
[1] G.G. Anderson and G.A. O’Toole, Bacterial Biofilms,
Current Topics in Microbiology and Immunology 322, p.
85 (Berlin, Springer, 2008).
[2] T.F. and G.A. O’Toole, Trends Microbiol. 9(1) (2001).
[3] J.D. Chambless, S.M. Hunt, and P.S. Stewart, Appl. En-
viron. Microbiol. 72, 2005 (2006).
11
[4] M. Jacobs, N. Gregoire, W. Couet, and J.B. Bulitta,
PLoS Comput. Biol. 12, e1004782 (2016).
[5] P.S. Stewart, Antimicrob. Agents Chemotherapy 40,
2517 (1996).
[6] P.S. Stewart, Antimicrob. Agents Chemotherapy 38,
1052 (1994).
[7] P.S. Stewart, T. Zhang, R. Xu, B. Pitts, M.C. Walters,
F. Roe, J. Kikhney J, and A. Moter, npj Biofilms and
Microbiomes 2, 16012 (2016).
[8] J.D. Vrany, P.S. Stewart, and P.A. Suci, Antimicrob.
Agents Chemotherapy 41, 1352 (1997).
[9] A.C. Aristotelous, I. Klapper, Y. Grabowski, B. Pabst, B.
Pitts, and P.S. Stewart, Phys. Rev. E 92, 022703 (2015).
[10] D. Taherzadeh, C. Picioreanu, and H. Horn, Biophys. J.
102, 1483 (2012).
[11] H. Beyenal and Z. Lewandowski, Biotechnol. Prog. 18,
55 (2002).
[12] W.W. Nichols, M.J. Evans, M.P.E. Slack, and H.L.
Walmsley, J. General Microbiol. 135, 1291 (1989).
[13] K. Anguige, J.R. King, and J.P. Ward, Math. Biosciences
203, 240 (2006).
[14] B. Birnir, A. Carpio, E. Cebrian, and P. Vidal, Commun.
Nonlinear Sci. Numer. Simulat. 54, 70 (2018).
[15] P.A.V. Gade, T.B. Olsen, P.O. Jensen, M. Kolpen, N.
Holby, K.A. Henneberg, and T. Sams, PLoS One 13,
e0198909 (2018).
[16] B. D’Acunto, L. Frunzo, I. Klapper, M.R. Mattei, and P.
Stoodley, Math. Biosci. 307, 70 (2019).
[17] E. Balsa-Canto, A. Lopez-Nunez, and C. Vazquez, Appl.
Math. Model. 41, 164 (2017).
[18] I. Klapper and J. Dockery, SIAM Rev. 52, 221 (2010).
[19] Q. Wang and T. Zhang, Solid State Commun. 150, 1009
(2010).
[20] T. Koszto lowicz, K. Dworecki, and S. Mro´wczyn´ski,
Phys. Rev. Lett. 94, 170602 (2005).
[21] T. Koszto lowicz, K. Dworecki, and S. Mro´wczyn´ski,
Phys. Rev. E 71, 041105 (2005).
[22] N. Alcazar–Cano and R. Delgado–Buscalioni, Soft Mat-
ter 14, 9937 (2018).
[23] O. Lieleg, I. Vladescu, and K. Ribbeck, Biophys. J. 98,
1782 (2010).
[24] A.G. Cherstvy, S. Thapa, C.E. Wagner, and R. Metzler,
Soft Matter 15, 2526 (2019).
[25] J.H. Jeon, N. Leijnse, L.B. Oddershede, and R. Metzler,
New J. Phys. 15, 045011 (2013).
[26] A. Godec, M. Bauer, and R. Metzler, New J. Phys. 16,
092002 (2014).
[27] I.Y. Wong, M.L. Gardel, D.R. Reichman, E.R. Weeks,
M.T. Valentine, A.R. Bausch, and D.A. Weitz, Phys.
Rev. Lett. 92, 178101 (2004).
[28] N.G. van Kampen and I. Oppenheim, J. Math. Phys. 13,
842 (1972).
[29] M.A. Lomholt, I.M. Zaid, and R. Metzler, Phys. Rev.
Lett. 98, 200603 (2007).
[30] I.M. Zaid, M.A. Lomholt, and R. Metzler, Biophys. J.
97, 710 (2009).
[31] I. Goychuk and P. Ha¨nggi, Phys. Rev. E 70, 051915
(2004).
[32] N. Korabel and E. Barkai, Phys. Rev. E 83, 051113
(2011).
[33] T. Koszto lowicz, Int. J. Heat Mass Transf. 111,
1322(2017).
[34] T. Koszto lowicz, Phys. Rev. E 99, 022127 (2019).
[35] P. Zhang, Y.P. Chen, J.H. Qiu, Y.Z. Dai, and B. Feng,
Trends in Microbiology 37, 214 (2019).
[36] M. Balouiri, M. Sadiki, and S.K. Ibnsouda, J. Pharmac.
Anal. 6, 71 (2016).
[37] M. Arabski, S. Wa¸sik, and Z. Drulis-Kawa, Clin. Micro-
bial. 2, 1000105 (2013).
[38] M. Arabski, S. Wa¸sik, M. Zych, W.  Lakomiec, and W.
Kaca, Acta Biochim. Pol. 60, 707 (2013).
[39] S. Lu, F. Liu, B. Xing, and E.K.L. Yeow, Phys. Rev. E
92, 062706 (2015).
[40] S. Singla, K. Harjai, and S. Chhibber, J. Antibiotics 66,
61 (2013).
[41] O. Kindler, O. Pulkkinen, A.G. Cherstvy, and R. Met-
zler, Sci. Rep. 9, 12077 (2019).
[42] M.E. Roberts and P.S. Stewart, Microbiology 151, 75
(2005).
[43] R. Metzler and J. Klafter, Phys. Rep. 339, 1 (2000).
[44] R. Metzler and J. Klafter, J. Phys. A 37, R161 (2004).
[45] J.N. Anderl, M.J. Franklin, and P.S. Stewart, Antimi-
crob. Agents Chemotherapy 44, 1818 (2000).
[46] J.H.P. Schulz, E. Barkai, and R. Metzler, Phys. Rev. X
4, 011028 (2014).
[47] R. Metzler, J.H. Jeon, A.G. Cherstvy, and E. Barkai,
Phys. Chem. Chem. Phys. 16, 24128 (2014).
[48] J. Crank, The mathematics of diffusion (Oxford, Claren-
don, 1975).
[49] T. Koszto lowicz, R. Metzler, S. Wa¸sik, and M. Arabski,
bioRxiv, doi: https://doi.org/10.1101/2020.02.26.966507
(2020).
[50] K. Dreschner et al., Proc. Natl. Acad. Sci. 113, E2066
(2016).
[51] R. Hartmann et al., Nature Phys. 15, 251 (2019).
[52] F. Diaz–Pascual, Nature Microbiol. 4, 2136 (2019).
[53] A. Penesyan, S.S. Nagy, S. Kjelleberg, M.R. Gillings, and
I.T. Paulsen, npj Biofilm Microbiomes 5, 34 (2019).
[54] P.S. Stewart, B. White, L. Boegli, T. Hamerly, K.S.
Williamson, M.J. Franklin, B. Bothner, G.A. James, S.
Fisher, F.G. Vital-Lopez, and A. Wallqvist, J. Bacteriol.
201(22), e00307-19 (2019).
